放射性医薬品の世界市場:産業分析および機会分析

◆英語タイトル:Radiopharmaceuticals Market - Global Industry Analysis and Opportunity Assessment, 2019-2029
◆商品コード:FMI20JA040
◆発行会社(リサーチ会社):Future Market Insights
◆発行日:2019年11月28日
◆ページ数:190
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Individual Price(1名様閲覧用)USD5,000 ⇒換算¥575,000見積依頼/購入/質問フォーム
Corporate Price(同一法人内共有可)USD7,500 ⇒換算¥862,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Future Market Insights社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査は放射性医薬品の現状および将来展望について、エグゼクティブサマリー、市場概要、市場背景、市場状況、需要分析、放射性同位元素別(テクネチウム-99、フッ素-18、ヨウ素-131、ロイテチウム-177、イットリウム-90)分析、用途別(腫瘍学、循環器、胃腸病学、神経内分泌学、神経学)分析、ソース別(サイクロトロン、原子炉)分析、エンドユーザー別(病院、画像診断センター、外来手術センター、がん研究所)分析、地域別分析、競争分析、調査手法に区分して掲載しています。
・エグゼクティブサマリー
・市場概要
・市場背景
・市場状況
・需要分析
・放射性医薬品の世界市場:放射性同位元素別(テクネチウム-99、フッ素-18、ヨウ素-131、ロイテチウム-177、イットリウム-90)
・放射性医薬品の世界市場:用途別(腫瘍学、循環器、胃腸病学、神経内分泌学、神経学)
・放射性医薬品の世界市場:ソース別(サイクロトロン、原子炉)
・放射性医薬品の世界市場:エンドユーザー別(病院、画像診断センター、外来手術センター、がん研究所)
・放射性医薬品の世界市場:地域別
・競争分析
・調査手法
【レポートの概要】

A recent market study published by Future Market Insights on the radiopharmaceuticals market includes global industry analysis for 2014 – 2018 & opportunity assessment for 2019 – 2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the radiopharmaceuticals market, the growth prospects of the market are obtained with maximum precision.

Chapter 01 – Executive Summary

The report initiates with the executive summary of the radiopharmaceuticals market, which includes a summary of key findings and statistics of the market. It also includes drivers and trends pertaining to the radiopharmaceuticals market.

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the radiopharmaceuticals market in this chapter, which will help them understand the basic information about the radiopharmaceuticals market. Along with this, comprehensive information pertaining to radiopharmaceuticals and their properties are provided in this section. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the radiopharmaceuticals market report.

Chapter 03 – Market Dynamics

This section gives information about drivers, and restraints of the radiopharmaceuticals market. This section also includes various opportunities and key trends of the radiopharmaceuticals market.

Chapter 04 – Market Context

This section gives information about upcoming pipeline products, PEST analysis, Porter’s Five Forces Model, and regulatory scenario of the radiopharmaceuticals market.

Chapter 05 – Global Radiopharmaceuticals Market Demand Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029

This section explains the global market value analysis and forecast for the radiopharmaceuticals market between the forecast periods of 2019 – 2029. This chapter includes a detailed analysis of the historical radiopharmaceuticals market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

Chapter 06 – Global Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029, by Radioisotope

Based on radioisotope, the radiopharmaceuticals market is segmented into Technetium-99, Fluorine-18, Iodine-131, Leutetium-177, Yttrium-90, Gallium-68, Gallium-67, Rubidium-82, Iodine-123, Iodine-125, Indium-111 and others. In this chapter, readers can find information about the key trends and developments in the radiopharmaceuticals market and market attractiveness analysis based on radioisotope.

Chapter 07 – Global Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029, by Application

Based on application, the radiopharmaceuticals market is segmented into oncology, cardiology, gastroenterology, neuroendocrinology, neurology, nephrology and others. In this chapter, readers can understand the market attractive analysis based on application.

Chapter 08 – Global Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029, by Source

Based on application, the radiopharmaceuticals market is segmented into cyclotrons and nuclear reactors. In this chapter, readers can understand the market attractive analysis based on source.

Chapter 09 – Global Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029, by End User

This chapter provides details about the radiopharmaceuticals market based on the end user, and has been classified into hospitals, diagnostic imaging centers, ambulatory surgical centers and cancer research institutes. In this chapter, readers can understand the market attractive analysis based on end user.

Chapter 10 – Global Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029, by Region

This chapter explains how the radiopharmaceuticals market will grow across various geographic regions such as North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan, and Middle East & Africa (MEA).

Chapter 11 – North America Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029

This chapter includes a detailed analysis of the growth of the North America Radiopharmaceuticals market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the radioisotope, application, source, end user, and countries in North America.

Chapter 12 – Latin America Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029

This chapter provides the growth scenario of the radiopharmaceuticals market in Latin American countries such as Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 13 – Western Europe Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029

Important growth prospects of the radiopharmaceuticals market based on its end users in several countries such as the U.K., France, Germany, Spain, Italy, Nordic Countries, Benelux and the Rest of Western Europe are included in this chapter.

Chapter 14 – Eastern Europe Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029

Important growth prospects of the radiopharmaceuticals market based on its end users in several countries such as Russia, Poland and the Rest of Eastern Europe are included in this chapter.

Chapter 15 – Asia Pacific excluding Japan (APEJ) Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029

In this chapter, China, India, Australia and New Zealand, ASEAN and Rest of Asia Pacific countries are the prominent countries in the Asia Pacific excluding Japan region that are the prime subjects of assessment to obtain the growth prospects of the APEJ radiopharmaceuticals market. Readers can find detailed information about the growth parameters of the APEJ radiopharmaceuticals market during the forecast period of 2019 – 2029.

Chapter 16 – Japan Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029

This section highlights the growth prospects of the radiopharmaceuticals market for Japan, during the forecast period of 2019 – 2029.

Chapter 17 – MEA Radiopharmaceuticals Market Analysis 2014 – 2018 & Opportunity Assessment 2019 – 2029

This chapter provides information about how the radiopharmaceuticals market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period of 2019 – 2029.

Chapter 18 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the radiopharmaceuticals market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are GE Healthcare, Siemens (Siemens Healthineers), Novartis (Advanced Accelerator Applications), Lantheus Holdings, Inc., Eckert & Ziegler, Positron Corporation, Bayer AG, Curium and Sotera Health LLC (Nordion, Inc.).

Chapter 19 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the radiopharmaceuticals market report.

Chapter 20 – Research Methodology

This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the radiopharmaceuticals market.

【レポートの目次】

1. Executive Summary

1.1. Global Market Outlook

1.2. Global Market Share Analysis

1.3. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Macro-Economic Factors

3.1.1. Increasing healthcare expenditure as a percentage of GDP

3.1.2. Rise in Aging population

3.2. Forecast Factors – Relevance & Impact

3.2.1. Increasing Installed base for PET and SPECT Scanners

3.2.2. Increasing Incidence of Cancer

3.2.3. Increasing Diagnosis Rate

3.3. Market Dynamics

3.3.1. Opportunity Analysis

3.3.2. Drivers

3.3.3. Restraints

3.3.4. Trends

4. Market Context

4.1. Reimbursement Scenario

4.2. Key Regulations

4.3. Value Chain Analysis

5. Global Radiopharmaceuticals Market Demand (Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

5.3. Market Value Growth Comparison

6. Global Radiopharmaceuticals Market Analysis 2014-2018 and Forecast 2019-2029, by Radioisotope

6.1. Introduction / Key Findings

6.2. Historical Market Size (US$ Mn) Analysis By Radioisotope, 2014–2018

6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Radioisotope, 2019-2029

6.3.1. Technetium-99

6.3.2. Fluorine-18

6.3.3. Iodine-131

6.3.4. Leutetium-177

6.3.5. Yttrium-90

6.3.6. Gallium-68

6.3.7. Gallium-67

6.3.8. Rubidium-82

6.3.9. Iodine-123

6.3.10. Iodine-125

6.3.11. Indium-111

6.3.12. Others

6.4. Market Attractiveness Analysis By Radioisotope

7. Global Radiopharmaceuticals Market Analysis 2014-2018 and Forecast 2019-2029, by Application

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Application, 2014–2018

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2019-2029

7.3.1. Oncology

7.3.2. Cardiology

7.3.3. Gastroenterology

7.3.4. Neuroendocrinology

7.3.5. Neurology

7.3.6. Nephrology

7.3.7. Others

7.4. Market Attractiveness Analysis By Application

8. Global Radiopharmaceuticals Market Analysis 2014-2018 and Forecast 2019-2029, by Source

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Source, 2014–2018

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Source, 2019-2029

8.3.1. Cyclotrons

8.3.2. Nuclear Reactors

8.4. Market Attractiveness Analysis By Source

9. Global Radiopharmaceuticals Market Analysis 2014-2018 and Forecast 2019-2029, by End User

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By End User, 2014–2018

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019-2029

9.3.1. Hospitals

9.3.2. Diagnostic Imaging Centers

9.3.3. Ambulatory Surgical Centers

9.3.4. Cancer Research Institute

9.4. Market Attractiveness Analysis By End User

10. Global Radiopharmaceuticals Market Analysis 2014-2018 and Forecast 2019-2029, by Region

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By Region, 2014–2018

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2019-2029

10.3.1. North America

10.3.2. Latin America

10.3.3. Western Europe

10.3.4. Eastern Europe

10.3.5. APEJ

10.3.6. Japan

10.3.7. MEA

10.4. Market Attractiveness Analysis By Region

11. North America Radiopharmaceuticals Market Analysis 2014-2018 and Forecast 2019-2029

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

11.3.1. By Country

11.3.1.1. U.S.

11.3.1.2. Canada

11.3.2. By Radioisotope

11.3.3. By Application

11.3.4. By Source

11.3.5. By End User

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Radioisotope

11.4.3. By Application

11.4.4. By Source

11.4.5. By End User

12. Latin America Radiopharmaceuticals Market Analysis 2014-2018 and Forecast 2019-2029

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

12.3.1. By Country

12.3.1.1. Brazil

12.3.1.2. Mexico

12.3.1.3. Rest of Latin America

12.3.2. By Radioisotope

12.3.3. By Application

12.3.4. By Source

12.3.5. By End User

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Radioisotope

12.4.3. By Application

12.4.4. By Source

12.4.5. By End User

13. Western Europe Radiopharmaceuticals Market Analysis 2014-2018 and Forecast 2019-2029

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

13.3.1. By Country

13.3.1.1. Germany

13.3.1.2. UK

13.3.1.3. France

13.3.1.4. Spain

13.3.1.5. Italy

13.3.1.6. Nordic Countries

13.3.1.7. Benelux

13.3.1.8. Rest of WE

13.3.2. By Radioisotope

13.3.3. By Application

13.3.4. By Source

13.3.5. By End User

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Radioisotope

13.4.3. By Application

13.4.4. By Source

13.4.5. By End User

14. Eastern Europe Radiopharmaceuticals Market Analysis 2014-2018 and Forecast 2019-2029

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

14.3.1. By Country

14.3.1.1. Russia

14.3.1.2. Poland

14.3.1.3. Rest of EE

14.3.2. By Radioisotope

14.3.3. By Application

14.3.4. By Source

14.3.5. By End User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Radioisotope

14.4.3. By Application

14.4.4. By Source

14.4.5. By End User

15. APEJ Radiopharmaceuticals Market Analysis 2014-2018 and Forecast 2019-2029

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

15.3.1. By Country

15.3.1.1. China

15.3.1.2. India

15.3.1.3. Australia & NZ

15.3.1.4. ASEAN

15.3.1.5. Rest of APEJ

15.3.2. By Radioisotope

15.3.3. By Application

15.3.4. By Source

15.3.5. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Radioisotope

15.4.3. By Application

15.4.4. By Source

15.4.5. By End User

16. Japan Radiopharmaceuticals Market Analysis 2014-2018 and Forecast 2019-2029

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

16.3.1. By Radioisotope

16.3.2. By Application

16.3.3. By Source

16.3.4. By End User

16.4. Market Attractiveness Analysis

16.4.1. By Radioisotope

16.4.2. By Application

16.4.3. By Source

16.4.4. By End User

17. Middle East and Africa Radiopharmaceuticals Market Analysis 2014-2018 and Forecast 2019-2029

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

17.3.1. By Country

17.3.1.1. GCC Countries

17.3.1.2. South Africa

17.3.1.3. Rest of MEA

17.3.2. By Radioisotope

17.3.3. By Application

17.3.4. By Source

17.3.5. By End User

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Radioisotope

17.4.3. By Application

17.4.4. By Source

17.4.5. By End User

18. Competition Analysis

18.1. Competition Dashboard

18.2. Competition Benchmarking

18.3. Competition Deep pe (Tentative List)

18.3.1. Siemens AG (Siemens Healthineers)

18.3.1.1. Overview

18.3.1.2. Service Portfolio

18.3.1.3. Profitability by Market Segments (Service/Channel/Region)

18.3.1.4. Sales Footprint

18.3.1.5. Strategy Overview

18.3.1.5.1. Marketing Strategy

18.3.1.5.2. Service Strategy

18.3.1.5.3. Channel Strategy

18.3.2. Positron Corporation

18.3.2.1. Overview

18.3.2.2. Service Portfolio

18.3.2.3. Profitability by Market Segments (Service/Channel/Region)

18.3.2.4. Sales Footprint

18.3.2.5. Strategy Overview

18.3.2.5.1. Marketing Strategy

18.3.2.5.2. Service Strategy

18.3.2.5.3. Channel Strategy

18.3.3. Novartis (Advanced Accelerator Applications)

18.3.3.1. Overview

18.3.3.2. Service Portfolio

18.3.3.3. Profitability by Market Segments (Service/Channel/Region)

18.3.3.4. Sales Footprint

18.3.3.5. Strategy Overview

18.3.3.5.1. Marketing Strategy

18.3.3.5.2. Service Strategy

18.3.3.5.3. Channel Strategy

18.3.4. Curium

18.3.4.1. Overview

18.3.4.2. Service Portfolio

18.3.4.3. Profitability by Market Segments (Service/Channel/Region)

18.3.4.4. Sales Footprint

18.3.4.5. Strategy Overview

18.3.4.5.1. Marketing Strategy

18.3.4.5.2. Service Strategy

18.3.4.5.3. Channel Strategy

18.3.5. GE Healthcare

18.3.5.1. Overview

18.3.5.2. Service Portfolio

18.3.5.3. Profitability by Market Segments (Service/Channel/Region)

18.3.5.4. Sales Footprint

18.3.5.5. Strategy Overview

18.3.5.5.1. Marketing Strategy

18.3.5.5.2. Service Strategy

18.3.5.5.3. Channel Strategy

18.3.6. Lantheus Holdings, Inc.

18.3.6.1. Overview

18.3.6.2. Service Portfolio

18.3.6.3. Profitability by Market Segments (Service/Channel/Region)

18.3.6.4. Sales Footprint

18.3.6.5. Strategy Overview

18.3.6.5.1. Marketing Strategy

18.3.6.5.2. Service Strategy

18.3.6.5.3. Channel Strategy

18.3.7. Sotera Health LLC (Nordion, Inc)

18.3.7.1. Overview

18.3.7.2. Service Portfolio

18.3.7.3. Profitability by Market Segments (Service/Channel/Region)

18.3.7.4. Sales Footprint

18.3.7.5. Strategy Overview

18.3.7.5.1. Marketing Strategy

18.3.7.5.2. Service Strategy

18.3.7.5.3. Channel Strategy

18.3.8. Bayer AG

18.3.8.1. Overview

18.3.8.2. Service Portfolio

18.3.8.3. Profitability by Market Segments (Service/Channel/Region)

18.3.8.4. Sales Footprint

18.3.8.5. Strategy Overview

18.3.8.5.1. Marketing Strategy

18.3.8.5.2. Service Strategy

18.3.8.5.3. Channel Strategy

18.3.9. Eckert & Ziegler

18.3.9.1. Overview

18.3.9.2. Service Portfolio

18.3.9.3. Profitability by Market Segments (Service/Channel/Region)

18.3.9.4. Sales Footprint

18.3.9.5. Strategy Overview

18.3.9.5.1. Marketing Strategy

18.3.9.5.2. Service Strategy

18.3.9.5.3. Channel Strategy

19. Assumptions and Acronyms Used

20. Research Methodology



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[放射性医薬品の世界市場:産業分析および機会分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆